Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Smoking 1Lung Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

pembrolizumab 29Carboplatin 27Specimen Handling 21durvalumab 20Pemetrexed 18Cisplatin 17Paclitaxel 16atezolizumab 15Nivolumab 15Magnetic Resonance Spectroscopy 15osimertinib 11Radiosurgery 11Radiotherapy 10Immunoglobulin G 10Etoposide 10Docetaxel 10Disulfides 10Radiation 9Taxes 8Gemcitabine 8Biopsy 8Blood Specimen Collection 7Standard of Care 6Practice Guidelines as Topic 6Ipilimumab 6Surveys and Questionnaires 5Platinum 5Bronchoscopy 5Bevacizumab 5Ramucirumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Lung Neoplasms × Phlebotomy × Clear all
NCT03881098 2026-06-03

The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy

University of Colorado, Denver

Phase NA Active not recruiting
240 enrolled
Thoracic

Carcinoma, Squamous Cell, Lung Neoplasms, Smoking

Data powered by HemOnc (CC BY 4.0) Colophon âš¡